Digoxin partly restores the abnormal circadian pattern of autonomic control during daytime but not during nighttime in patients with congestive heart failure  by Brouwer, Jan et al.
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• Coronary and Oontm~ila Effects of lntrecomnnry 
Bmdylrdnin and Their Modulation by AGE Inhibitor 
in Normal Conec lo~ Dogs 
ROmi HouIH, Jinbo Su, Fabdce Barbe, ROmi Choussat, Bertrand Crozatier, 
Luc Wd~nger. INSERM U400, Facult~ de M~[~ecine, CrOtett, France 
inhibition of bra4yldnin (BK) degradation may contribute to the hamodynamio 
effects of angiotansin converting enzyme (ACE) inhibitors. In this study, we 
examined in normal conscious dogs, the coronary and contractile ffects of 
intracerona~ (ic) BK and their medul~on by ACE inhibitor, To avoid neu- 
rorsflex activations low doces of SKwere used (0.1,1, 3,10 nanogr~ 
lc bolus). The effects of i,c. BK were also examined in the presence of the 
ACE inhibitor enalapdlat (E) given intracoronarily (0,75 rag) and orally (20 
rag). Seven mongrel dogs were chronically instromented with left vantdcoter 
(LV) mlcromenometer, amt~ catheter, corormry flow probe, circumgex coro- 
nary catheter and ptescelactlo crystals for the measurement of LV posterior 
regional ventriceiar function. In absence of systemic hemedynarelo changes, 
low doses of BK increased ose-dependently coronary blood flow (CBF ve- 
!getty: 30 :t: 5, 42 ± 7, 45 ~ 8, 48 :E 7 cm/s, respectively, frore 19 =1:3 cites). 
The increase in CBF induced by BK was associated with an increase in end- 
diastolic regional wall thickness (BK 10 ag/kg: from 11.9:1:1.1 to 12.4:1:1.1 
mm, p < 0.01) without change in LV regional well thickening. Intmceronary 
enalapd~at extended sign'dicantty he duration of the rtsa in CBF induced 
by BK (10 ng/kg: from 42 :~ 5 to I16 ± 15 sac, p < 0,01) without change 
in peak effect. After enatapdlat a further increase in the end-diastolic w~| 
thickness was observed (E + BK 10 ng/kg: 13.4 -t- 1.2 mm, p < 0.05) with 
no change in regional con~.~l~. Simi'ar findings were observed one hour 
after oral administration of enalapdl. Thus, in normal conscious dogs, SK 
increases coronary blood flow and end<liaatofic wall thickness with no effect 
on myocardial contractility. Infraceronary or oral administration ofenatapdlat 
does not change the contractile response to BK but prolongs the coronary 
vasnditator effect of bmdykinin. 
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• Hsemodynamlo and Endocrine Effects of ANP and 
BNP in Pulmonary Heart Disease 
Rot~ert t.Cargill, 8finn J. Upworth. Oepartmenf of Clinica~ Pharmacology, 
Unive~ity of Dundee, Scotland, UK 
We have aludled the effects of atdal natdurstio peptide (ANP) and b-type 
nalrluratic peptido (BNP) in eight patients with pulmonary heart disease 
secondary to hypoxaemio lung disease. E~ pat!ant was studied twice in 
cross-over fashion. After resting to reach bassline hasmedynamiss, ubjects 
were given a 20 minute placebo infusion, followed by either ANP or BNP 
(3 pmol/kg/min than 10 pmol/kg/min for 20 rains each). Responses were 
measored at baseline, after placebo infusion, and following low then high 
dose ANP or BNP. 
Baseline conditions were similar and placebo infusion had no aignificant 
effects on either study day. Low dose ANP and BNP significantly reduced 
m- :m pulmonary artery pressure (MPAP) from baseline by 3.7 :t: 1.1 mmHg 
and 3.0 ± 1.1 mmHg respectively High dose ANP and BNP further educed 
MPAP from baseline by 7.1 ~: 1.1 mmHg and 7.1 at: 1.6 mmHg respectively. 
ANP and BNP had no confounding systemic haemedynareio effects and 
did not woman artedal oxygenation, Plasma aldostarona was significantly 
suppressed by ANP ( -  156 :t: 48 pmol/1 after fuw dose, - 275 :E 57 pmci/1 
after high dose) and by BNP ( -  92 =E 36 pmol/I after low dose, - 159 -v 55 
pmol/1 after high dose), 
ANP and BNP soused dose-related pulmonary vesedilatatlon and had 
favoursbla neurehormonal effects by suppressing aldoaterona, without were. 
an(ng oxygen saturation or affecting systemic haemodynamlce, These ac- 
tions might herefore be exploited as a novel therapeutic strategy in patients 
with pulmonary heart disease. 
Long Term Effects of Ctclatanine on Secondary 
Pulmonary Hypertension 
Alain SasdJlan, Fran(;cls Philip-Jolt, Franck Paganegi, Alaln Amaud, 
Samuel Levy. University of Morse!lie, Cardiology Dpt, CHU Noro~ 13915 
Marseille, France 
Clcletenine ((3), an antihypartensive furopyrld[na dodvative drug was shown 
to enhance the production of endogenous prostacyciln. The goal of the 
present work was to evaluate the possible effecla of C on pulmonary artery 
hypertension (PAH) secondary tO chronic obatm~ve lung dJsaase (COLD). 
In a doul~e blind placebo controlled study, we evakmted the long term effeots 
of C (SO mg per ca (laity) on hamndynamios and btood gases of 33 patients 
(pts) sutfedng from PAH secondary to COLD. Pie receiving C (11) and those 
(12) who had a placebo (P) were catheterized betom traatment (TO) then 3 
months iT3) and 12 months later (T12). 
Results (mean ± SEM): 
CIcletan[ne Placebo C/P 
TO 13 T12 TO T3 3"12 
CI 2.8=1:0.2 3330,2* 3,230.2 2.830,2 2.830.1 ~230,1 ce 
MPAP 27 =t: 2 23 =l: 2" 22-*.2* 303)-2 29:~3 2932 <0.05 
PWP 114-1 1031 9:E1 12±1 1331 11=1:1 ns 
TPR 454:b28 36P.:~31" 8814-43" 507348 474±47 48934 <0,05 
Pa02 6432 5833* 5933* 60~=3 6133 5e.~.4 n= 
Gk cardiac index (Umlrdn~-), MPAP: mean puimenaly artery pressure, PWP: po|mecery 
wage pmuum (mmHg), TPR: total pulmonary esistance (dynes.era.We). PC02 (rnmHg). 
*d~er,~nca (p < O.0S) between TO and 1'3 er/T12. 
A signiticant decrease in MPAP and TPR was observed in group C and 
between C and P attar 3 months of treatment and persisted after 12. Pa02 
decreased slightly in group C but the difference with group P was not sig- 
nificant, These results suggest that tong term treatment with tow dose C 
can induce an effective pulmonary rased!!st!on in pts with PAH secondary to 
COLD, This vasodtlation is associated with a alight venous admixture. 
~ T h e  Pulmonary Circulation Is on Important Site for 
Both Clearance and Prnduction of  Endotheiln-1 in 
Humans 
Jecelyn Oupuis, Gilbert Gosaelin, Duncan J. Stewart, Peter Cemacek. 
Montreal Heart Institute and Montreal Genera! Hospital, Montreal, C, anade 
Animal studies suggest a meier rate of the pulmona~ circulation in the 
clearance of circulating endotheiln-1 (ET-1). The contribution of the human 
pulmonary circulation to plasma ET-1 has however never been quantified, 
To precisely quantify and discern botwean ET-1 clearance and produ~on, 
we studied patients during elective coronary anglography by combining the 
multiple Indicator dilution technique with simultaneous measurement of im- 
munoreastive ET-1 levels in companion aortic and pulmonary artery blood 
samples. A be!us containing trace dosaa of [125]-I-ET.1 and Evens blue dye 
was injected into the pulmonary artery and timed samples from the aorta 
were collected to construct a dlfution cunm. Ni pet!ante had normal isft yen- 
trice!or election haction (61 :E "P/,; M -I- SO) and baseline puimonmy and 
systemic hemodynamlss (mean pulmonary artery pmasure: 16 ± 4 mmHg). 
Mean cumulative tracer ET-1 extraction was 47 :~ "P/o during a s|nl;~e put- 
monary transit ime, The ET-1 extracted oes not return to the circulation and 
can be characterized by a sequestration rate constant: K=~ = 0,048 -~ 0.019 
s -1. There was however no significant difference between immunoraactive 
ET-1 !eveis from the pulmonaw artery (0.61 ~ 0,29 pg/ml) end aorta (0.67 :E 
0.32 pg/ml): the normal ung consequently produces an amount of ET-1 that 
is quantitatively alrollar to the quantity that has been extracted. Conclusion: 
The human tung is an important site for beth clearance and production of 
ET-1. There is a normal physiologic "balance" of ET-1 across the pulmonary 
circulating explaining the absence of difference in attedovenoua ET-I levels 
despite a 47 :E 7% clearance. Reduced pulmona,'y clearance or increased 
production of this paptlde may contribute to the increase in circulating levels 
found in various cardiovascular conditions. 
~ Digox!n Partly Restores the Abnormal Circadian 
Pattern of Autonomic Control During Daytime but 
Not D. u_rin.g Nighttime In Patients With Congsetlve 
r lel l l l  PSllUre 
Jan Breuwer, Dirk J. van Valdhuisen, Ado J. Man in 't Void, Peter 
HJM, Ounsefman, Jaap Hasksma, K.L Lie for the DIMT Study Group. 
Groningen, The Netherlands 
Recently, we den~onctmted that treatment w~h dtgoxin enhances cardiac 
vega! tOne in patina-Its with mtld to moderate congestive heart failure (CHF). TO 
evaluate if this effect Is present hroughout the day, we studied the clmadlan 
pattern of h~.art rate variability (HRV) parameters In 22 CHF patients (age 60 
:E 1 years (mean :E SEM), ejection fraction 0.30.4- 0.0I) and in 18 healthy 
controls (age 55 4-1 years), The CHF patisnts were treated with digoxln 0.25 
mg once daily for 3 months, Analysis of HRV was performed using 24 Hr 
Holler recordings and included time end frequency domain parameters. At 
baseline, all HRV pommeters ahowed a reduced circadian pattero In the CHF 
patients as competed to the haatthy controls. After treatment with digoxlr~ 
pNNSO increased significantly from 2,9 at: 0.7% to 4.9 ~ 1 .~ (p < 0.05) 
dudng daytime hours in the CHF petiants. Highz ,fi~:luency poW~z(0.15-O 40 
Hz) also showed an increase from 117 ± 22 ms to 175 ~- 34 ms (p < 0.01) 
dudng daytime bourn, Low frequency power (0.04-0.15 Hz) showed a small 
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increase during daytime I~um from 389 4- 71 ms2 to 479 4- 83 ms 2 (p < 
0.05). Outing nighttime hours, no significant changes were observed in any 
of the HRV parameters. Compared to tho healthy controls, a partial recovery 
of the circadian pattam of pNN50 and of high frequency power was observed 
after digoxin treatment only dudng daytime. 
We conolude that already In the early stages of CHF, the circadian pattern of 
autonomio control is disturbed. Digexln partly restores the circadian paftem 
of especially parameters aSsociated with cardiac vagel tone, only during 
daytime bourn. DIgoxln apparently enhances cardiac vagal tone in tho setting 
of noumendocrine activation. The clinical significance of these findings need 
further study. 
Hypertension 
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~ Cyclospodne Hypertension: for Induced Evidence 
Maintained Baroreflex Circulatory Control 
Daniela Lucini 1 Richard V. Milani2 Hector O. Ventora2, Mandsep 
R. Mehra 2, Franz Messerii 2, Joseph P. Murgo 2, Alberto Malliani I
Massimo Pagani ~ . 1 Cenfro Ricerche Cardiovascolari, CNR, Medicina 
Intema II, Ospedale %. Sacco," Unfversfta di Milano, ftaly; ~ Ochsner 
Medical Insitutloos, New Orleans, LA 
To elucidate the potential mechanisms underlying cyciospedne induced hy- 
pertension (CYA-H), the functional integrity of the baroreflex arc, the main 
reflex regulatory mechanism "coupling" the peripheral circulation to the heart, 
was assessed by a validated measure of barcraflex function. Index alpha (ar- 
terial pressure-cardiac period gain) waS determined in four groups of subjects 
matched for age: I) 23 orthatoplc heart transplant recipients (Htx), II) 8 ortho- 
topic solid organ transplant (liver or kidney) recipients (Otx), III) 13 patients 
with essential hypertension (Hi), IV) 18 normal subjects. Htx, Otx and Ht 
patients were all treated with similar dihydropyridine calcium enW blockers, 
and HTx and OTx were trcatcd with cyclosperine. Results: 
SAP RR Vaflance RR Indexa#~ha 
(mm Hg) (ms) (rns ~.) (ms/mmHg) 
OTx 1334-11 | 9024-182 J 2192=f=2811J 11.7±6.6 J ]
NI 1194-10J ~ 8S9±121 19374-1123 13.54-6.4] 
Ht 1414-12 8534- 89 1197~ 842 7.34-3.6 = 
] = p < 0.05, ANOVA with eonferroni correction..qAP =systolic artedal pressure 
Conclusions: 1) CYA-H in heart tranplant recipients demonstrates a loss 
of bamretlex integrity due to denewaticn related uncoupling. 2) Compared 
to patients with essential hypertension, solid organ transplant recipients with 
hypertension demonstrate a maintained baroreflex response as evidenced 
by a lack of reduction in index alpha. 3) These findings provide evidence 
for maintenance of barcretiex circulatory control in dihydropyridlne treated 
CYA-H. 
~ '~-~ Progneatic o f  Exerciee-induced Implieutlons 
Hypertension With or  Without Increase in Exerctse 
Ejection Fraction: A 10 Year FoUow-Up Study 
Kathrin Bider, Matthias Pfistarer. Jan MOiler-Brand Division of Cardiology, 
University Hospital Basel, Switzerland 
No increase in ejection fraction (EF) during exercise (Ex) in presence of 
Ex*indused hypertension has bean thought o be duo to increased afterload 
rather then myocardial dysfunctiorVischemia. To assess prognostic implica- 
tions of this finding, 110 p:ltients (pts) with normal blood pressure (BP) at 
rest but age-adjusted Ex-induced hypertension and no CAD based on his- 
tory, clinical findings and Ex-ECG were followed-up after 10 4- 2 years by 
questionnaire. During a symptom-limited supine bicycle Ex-tsst at baseline 
combined with standard radionuciide ventdculography, heart rata increased 
from 73 4- 11 to 128 4- 19 bpm, systolic BP from 140 4- 11 to 216 4- 17 mm 
Hg and diastolic BP from 82 4- 6 to 91 4-12 mm Hg (all p < 0.01). In 46 pts 
EF increased by >_ 5% (group A) from 59 4- 8 to 69 4- 9"/0 (p < 0.01), whereas 
it remained unchanged or decreased in 64 patients (group B; 64 4- 9% at 
rest, 62 4- 10% during Ex, p ns). Group A pts were younger (50 4- 9 vs 55 4- 
9 years, p < 0,05) and reached a higher average workload (101 4- 30 vs 87 
4- 29 watts; p < 0.05) than group B pts. During the 10 year follow-up, 9 pts 
(6%) died for a mortality rate of 0.8% par year;, mortality was not significantly 
different between group A and B pts. However, non-fatal myocardial infarc- 
tion (A: 2°/o, B: 13%) and PTCA or CABG surgery (A: 3%, B 19%) were more 
frequent in group B than group A pts resulting in a significant difference in 
non-fatal ischemic events (myocardial infarction or revasculadsation) of 11% 
(A) vs 32% (B; p < 0.05). Similarly, the rate of angina pectods was higher in 
group B than In group A patients (B: 22%, A: 2%; p < 0.05). 
We conclude that during long-term follow-up, Ex-induced hypertension 
associated with a normal EF increase during Ex has a good prognosis, 
whereas an abnormal EF response to Ex carries an increase(] nsK of non- 
fatal ischemic events and may be an early marker of myocardial disease. 
. .~ .en  Suppien~. nl~ie.n Decreases Total Body 
~orapmephdne ~pi l lover In Pedmenopausal 
women 
Krishnankutty Sudhlr, Murray O. Esler, Garry L Jannings, Paul 
A. Komasaroff. Baker Medical Research Institute And Alfred Hospital, 
Melbourne, Australia 
Estrogens are reported to ettanuate cardiovascular responses to stress and 
provide pmtestion against the development of cardiovascular disease in 
women. The mechanisms underlying these effects are not well defined. We 
hypothesized that estrogen might influence release of catecholaminas and/or 
glucocorilcoids, the major hommnat determinants of responses to stress. We 
therefore measured noreplnophrine piilover to plasma, and plasma cortisot 
levels in 12 perimenopausel women before and after 6 weeks of estrogen 
suppismantation (eetradiol valerata 2 mg daily, n = 7) or placebo (n - 5). Total 
body and forearm norspinephdne spillover were measured using radictracer 
methodology. Forearm blood flow (FBF) was measured by venous occlusion 
plethysmography. Cortisel was measured by radioimmunoassay. Estrogen 
supplementation caused a significant decrease in total body norepinephrine 
splilover (pro: 528 4- 110, post: 355 :J: 45 rig/rain, p < 0.05), but there 
was no change following administration of placebo. Forearm epiilover of 
noreplnephrine was unchanged by either estrogen or placebo. There waS a 
tendency for plasma cortisel concentration to desmase following estrogen 
administration (pro: 325.4- 73, pest: 278 4- 71 ), but this change did not mash 
statistical significance. Thus, estrogen supplementation i perimenopausal 
woman decreases total body epillovar of norepinephdne without influencing 
regional splilover in the forearm. A decrease in norepinephdne spiilover from 
visceral organs such as the kidneys, heart and liver probably undedias the 
fall in total body splllever induced by estrogen. The relation of these changes 
to estrogen-induced cardiovascular protection remain to be determined. 
9~'5-9~ Dietary Salt Restriction Does Not Restore the 
Autonomic Imbalance of  Essential Hypertension 
Philip R Binldey, Mohammed Queder, Emmanuel L Bravo, Fetnst 
M. Fouad-Tarazi. The Ohio State University, Columbus, OH; The Cleveland 
Clinic, Cleveland, OH 
Essential hypertension (HTN) is thought to be related to an imbalance of 
autonomic rnguistOry mechanisms resulting in abnormalities of vascular tone 
and sustained increasas in Mood pressure. Increased dietary salt intake is 
also known to play a role in the elevation of blood pressure in some patients 
(pta) with HTN. However, it is unknown whether mechanisms dependent 
on distary sodium balance may contribute to the autonomic abnormalities in 
these patients. We Itypothesized that high salt diet increases sympathetically 
mediated autonomic activity in hypertansivo pts, as compared to low salt diet. 
We studied autonomic tone (spectral analysis of heart rate variability, HRV) in 
normotonsivas (nis) and ptswith HTN and investigated the influence of dietary 
salt intake on autonomic balance from supine resting e lec t r i c  
recordings. There were 20 nis, 12 HTN maintained on a low salt diet (IS 
for 5 d) and 11 HTN with a high salt diet (HS for 7 d). Both HS and LS 
HTN demonstrated autonomic imbalance which significantly differed from 
his. There was a significant {p < 0.0001 ) two-fold increase in the percentage 
of sympathetically mediated low frequency heart rate variability (68 4-15% in 
L$ and 63 4-19% In HS varsus 34 4-15% in nis), a significant (p < 0.0001) 
reduction in the parsentage of parasympathetically mediated high frequency 
HRV (31 4-14% in IS and 36 4- 19% in HS versus 65 4- 16% in nts). None 
of these measures of HRV differed between the LS and HS HTN pta (all p > 
0.05). We conclude that the increase in sympathetic drive and reduction f3f 
parasympathetic tone in HTN demonstrated by these data are indepamJent 
of dietary salt intake. 
~ Asso©iatlon of  the D/I Polymorphiem of  the ACE 
Gene With Pulse ~ r a  in Nomtotensive Men 
Hans W. Hense, JuRa Stieber, GOntar A.J. Riegger, Hen'bert Schunkert. 
Universities of MOnster and Regensburg, and GSF MOnchen, Germany 
Recent reports indicate that engiotensin converting enzyme (ACE) levels 
are related to structural efferations of the left ventricle and the arterial wall, 
particularly iw low risk subjects. We investigated the association of serum ACE 
